Transcription factors and epigenetic mechanisms of action: insights and perspectives from NMCS 2016
Researchers from Washington University (St Louis, MO, USA) have found a potential means to disrupt the spread of Zika and similar viruses in the body, research that could lead to future therapies.
Researchers from the Walter and Eliza Hall Institute (Victoria, Australia) have discovered how a novel class of anti-cancer therapeutics kills cancer cells, a finding that could help explain drug resistance in cancer cells.
Researchers from the Fred Hutchinson Cancer Research Center (Seattle, WA, USA) have revealed that drug resistance in cancer may be partially due to high pressure in solid tumors, a state that could be overcome by treating tumors with an enzyme.
Researchers at the Massachusetts Institute of Technology (Cambridge, MA, USA) and Brigham and Women’s Hospital (Boston, MA, USA) have developed novel nanoparticles capable of delivering anti-obesity therapeutics directly to fat tissue.
Histone deacetylase inhibitors could improve success rate of immunotherapy against lung cancer
An international team has developed a novel therapeutic compound effective in inhibiting the most deadly species of malaria-causing parasite.
Researchers co-led by scientists from the University of Kent (Canterbury, UK) and Goethe University (Frankfurt, Germany) have identified a first step in the design of a new generation of anti-cancer therapeutics.
A team from the Walter and Eliza Hall Institute (Melbourne, Australia) have resolved a mystery about the action of a novel class of anti-cancer drugs, nutlins, with potential implications for future cancer treatments.